ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 152 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $40,000 | +8.1% | 24,815 | +88.3% | 0.01% | +16.7% |
| Q2 2018 | $37,000 | -65.7% | 13,178 | -64.5% | 0.01% | -68.4% |
| Q4 2017 | $108,000 | -21.7% | 37,171 | +13.5% | 0.02% | -40.6% |
| Q1 2017 | $138,000 | -68.1% | 32,757 | -41.0% | 0.03% | -72.6% |
| Q2 2016 | $433,000 | +263.9% | 55,521 | +260.4% | 0.12% | +265.6% |
| Q1 2016 | $119,000 | – | 15,407 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |